LUNG CANCER QUIT NATIONAL TOBACCO CAMPAIGN. PART A LUNG CANCER.
Lung Cancer Session · lung cancer, colorectal cancer, sarcomas, and all other solid tumors. He has...
Transcript of Lung Cancer Session · lung cancer, colorectal cancer, sarcomas, and all other solid tumors. He has...
16th October 202017:00 Hrs - 21:10 Hrs UAE Time
VIRTUAL CONGRESS
CLICK HERE TO REGISTER
Lung Cancer SessionE - BROCHURE
2
Lung Cancer SessionE - BROCHURE
Alona ZerRabin Medical Center, Israel
Byoung Chul ChoYonsei University College of Medicine South Korea
Alfredo AddeoGeneva University Hospital, SwitzerlandDr. Alfredo Addeo is a senior oncologist at the Geneva University Hospital, Geneva Switzerland. Dr. Addeo received his training at the University of Turin (Italy)and completed a MD in oncology at the University school of medicine of Turin (Italy). He is the lead for several translational research project his department: his main interests at the moment are liquid biopsy, ctDNA and TMB in thoracic malignancies.
Dr. Alona Zer is affiliated to Rabin Medical Center, Petah-Tikva, Israel. , Rabin medical university. Dr. Alona Zer is currently providing services as Professor. Dr. Alona Zer has authored I145and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Alona Zer contributions have acclaimed recognition from honourable subject experts around the world.
He received Doctor of Medicine and License of general Medicine in 2001, Master of Medicine – Yonsei University College of Medicine in 2005 and Specialist in Medicine in 2006.He was awarded Boryeong Research Award(Korean Society of Medical Oncology) and Exellence Award for Prolific Research(Yonsei University College of Medicine) in 2017 .2017 The Best Professor Award (International Cooperation)(Severance Hospital, Yonsei University College of Medicine) and 51stYuhan Medical Award (Excellence Award) in 2018. He is an Active member of Lung Cancer and Head & Neck Cancer Committee of KCSG.
3
Lung Cancer SessionE - BROCHURE
Emad DawoodTawam Hospital, UAE Dr.Emad Anwar Dawoud, MD, PhD is a Consultant Clinical Oncology at Tawam Hospital (Affiliated with Johns Hopkins) Al Ain, UAE
Dr.Fathi Al Azribi is a Consultant Medical Oncologist & Division Chief at Tawam Hospital Medical Oncology Fellowship Program Director.
Hassan Jaafar , M.D., is Hemato-Oncology Consultant of Oncology Center.His Major areas of interests are including breast cancer and gynecological cancers, lung cancer, colorectal cancer, sarcomas, and all other solid tumors. He has overall 26 years of professional experience. After receiving medical degree from Medical School Al-Mustanseria University, he had 3 years of residency in Internal Medicine, Makassed General Hospital affiliated with American University of Beirut and 3 years of fellowship Hematology-Oncology American University of Beirut.
Fathi AzribiTawam Hospital, UAE
Hassan JafferSheikh Khalifa Specialty Hospital, UAE
4
Lung Cancer SessionE - BROCHURE
John R GosneyLiverpool University Hospitals, UK
Professor John Gosney is a Consultant Thoracic Pathologist at Liverpool University Hospitals and Professor of Thoracic Pathology at the University of Liverpool. He also holds a Visiting Professorship in Thoracic Pathology at Charles University, Prague, Czech Republic. He has published over 150 research papers in peer-reviewed journals and written numerous reviews and chapters in books. He is a President of the Association of Pulmonary Pathologists. He works widely with the pharmaceutical and diagnostics industries advising on the development and application of diagnostics to the targeted therapy of lung cancer. In 2017, he received a Lifetime Achievement Award from the British Thoracic Oncology Group for his contribution to thoracic oncology.
He is currently the President and convener of Indian Cooperative Oncology Network (ICON).He has so far published over a hundred research and review articles/papers in journals of national and international repute.He has so far undertaken over 80 projects as Principal Ivestigator and Co-Investigator.He is a member of many international and national scientific societies and associations and has delivered talks in several conferences.
Dr. Kaltar Das is a Senior Specialist Medical Oncologist at Dubai Hospital, Dubai, UAE
Kaltar DasDubai Hospital, UAE
Kumar PrabhashTata Memorial Hospital, India
5
Lung Cancer SessionE - BROCHURE
Maroun El KhouryAmerican Hospital Dubai, UAE
Maximilian HochmairOtto-Wagner Hospital, Austria
Dr. Maroun El Khoury completed his basic medical training from Saint Joseph University Schoolof Medicine Beirut, Lebanon in 1999. He is also a member of the American Society of ClinicalOncology, American Society of Hematology and American Academy of Pain Management. Dr. Maroun El Khoury›s specialty is Oncology and currently work as a Consultant Oncologist.
Dr.Mohsen Mokhtar is a professor of clinical oncology in Al-Kasr Al-Aini Medical School. Dr.Mokhtar has more than 20 years of experience in hospital management and he is currently the chief medical director in Elaj group covering the clinical and medical audit of group facilities. He is now focusing on clinical trials in breast, gynecological and prostate cancers.He is an active member of the Arab Medical Association Against Cancer (AMAAC), the Egyptian Cancer Society (ECS) and the Egyptian Hemato- Oncology Group (EHOG).
Maximilian Hochmair is an oncologist at Otto-Wagner Hospital, Austria
Mohsen MokhtarCairo University Kasr El Aini Medical School, Egypt
6
Lung Cancer SessionE - BROCHURE
Nouri BenniniTawam Hospital, UAENouri Bennini has served as Consultant Oncologist at the Tawam Hospital in Al Ain, United Arab Emirates, since 1999. He received his general medicine diploma in 1988 from the University of Constantine in Algeria and undertook residency in medical oncology at the University of Bordeaux, France. At the University of Montpellier, France, Dr. Bennini specialised in breast diseases. He has published several scientific papers and contributed to a number of oncology conferences.
Dr.Nitesh Rohatgi is a senior consultant in Medical Oncology at Max Hospital in Saket, who was till recently working at the prestigious London Oncology Clinic (Leaders in Oncology care), Harley Street, London. He is a fellow of the Royal Society of medicine and has much publication to his name. He was trained in medical oncology, palliative medicine and teenage young adult’s cancers in United Kingdom.
Professor Popat has both a private and an NHS practice at The Royal Marsden. Professor Sanjay Popat is a Consultant Thoracic Medical Oncologist at The Royal Marsden and Honorary Clinical Senior Lecturer in the Molecular Genetics and Genomics Group at the National Heart and Lung Institute, Imperial College London.He is a specialist thoracic oncologist, and is an internationally recognised expert in the treatment of lung cancer, mesothelioma and cancers of the thymus (thymoma and thymic carcinoma).
Nitesh RohatgiMax Hospital, India
Sanjay PopatThe Royal Marsden, UK
7
Lung Cancer SessionE - BROCHURE
Solange PetersCentreHospitalier Universitaire Vaudois, Switzerland
Srinivas ChilukuriApollo Proton Cancer Centre, India
Ullas BatraRajiv Gandhi Cancer Institute, India
Prof. Peters is currently in charge of teaching and patient care in the area of medical oncology and thoracic malignancies at the Department of Oncology of Lausanne University, where she is building a translational programme in collaboration with the molecular oncology laboratory directed by Prof. D. Hanahan and Prof. E. Meylan in Swiss Federal Institute of Technology in Lausanne and the Ludwig Institute. Prof. Peters’ main field of interest is new biomarker discovery and validation in preclinical and clinical settings.Prof. Solange Peters is an active member of the educational programme within ESMO. Prof. Peters is currently President (2021 – 2020) of the European Society for Medical Oncology (ESMO) and a member of the ESMO Faculty for Lung and Other Thoracic Cancers.
Dr. Ullas Batra obtained his DM in Medical Oncology from the prestigious Kidwai Memorial Institute of Oncology. He has gained widespread experience in the management of various malignancies like Lung cancer, breast cancer, GI Cancers and hematological malignancies etc. He has also done preceptorship in various International Institutes like MD Anderson Cancer Centre, USA, Royal Adelaide Hospital, Australia.He has participated as a Principal investigator and co-Investigator in various phase II and III clinical trials.
Dr. Srinivas Chilukuri MBBS, MD, PDCR is an Radiation Oncologist Apollo Proton Cancer Centre, India
8
Lung Cancer SessionE - BROCHURE
Excellence in Oncology Care | cancercongress.ae
Lung Cancer SessionE - BROCHURE
17:00 – 17:10 Opening RemarkSpeaker: Kumar Prabhash, India
17:12 – 17:45 Session 1Session Chair: Kumar Prabhash, India
17:12 – 17:27 Liquid Biopsy – State of Art in Lung CancerSpeaker: Byoung Chul Cho, South Korea
17:30 – 17:45 Advances in Proton Therapy in Lung CancerSpeaker: Srinivas Chilukuri, India
17:47 – 19:30 Session 2Session Chair: Kaltar Das, UAE
17:47 – 18:02 ASCO/ESMO Update of Targeted Therapy in Lung Cancer Speaker: Mohsen Mokhtar, Egypt
18:04 – 18:24 1L EGFR mNSCLC Management UpdateSpeaker: Maximilian Hochmair, Austria
18:26 – 18:36 Beyond EGFR Mutations – What are the OptionsSpeaker: Sanjay Popat, UK
18:38 – 19:08 Panel DiscussionModerator: Ullas Batra, India Panel: Sanjay Popat, UK | Kumar Prabhash, India | Kaltar Das, UAE Alona Zer, Israel | Maximilian Hochmair, Austria | Rajiv Kaushal, India
19:10 – 19:30 Genomic Alterations in NSCLC and TCSpeaker: John R Gosney, UK
Supported By: Apollo
Supported By: Lilly
LUNG CANCER SESSION PROGRAMFRIDAY, October 16, 2020
17:00 Hrs – 21:10 Hrs UAE Time
Supported By: NewBridge
Supported By: Lilly
9
Lung Cancer SessionE - BROCHURE
Excellence in Oncology Care | cancercongress.ae
Lung Cancer SessionE - BROCHURE
19:32 – 20:55 Session 3Session Chair: Hassan Jaffer, UAE | Emad Dawoud, UAE
19:32 – 19:47 ASCO/ESMO Update of Immunotherapy in Lung Cancer Speaker: Sanjay Popat, UK
19:49 – 20:04 Challenges and Treatment Approaches in Management of ES-SCLC:Evaluating New Approaches to Improve OutcomesSpeaker: Sanjay Popat, UK
20:06 – 20:16 CheckMate 227Speaker: Solange Peters, Switzerland
20:18 – 20:33 Long Term Outcomes with Checkpoint Inhibitors in NSCLCSpeaker: Alfredo Addeo, Switzerland
20:35 – 21:05 Panel DiscussionModerator: Nitesh Rohatgi, IndiaPanel: Sanjay Popat, UK | Alona Zer, Israel | Solange Peters, SwitzerlandMohsen Mokhtar, Egypt | Emad Dawoud, UAE | Fathi Azribi, UAEMaroun Khoury, UAE | Nouri Bennini, UAE
21:05 – 21:10 Question & Answers
Closing Remark
Supported by: AstraZeneca
Supported by: MSD
LUNG CANCER SESSION PROGRAMFRIDAY, October 16, 2020
17:00 Hrs – 21:10 Hrs UAE Time
10
Lung Cancer SessionE - BROCHURE